Raivo Uibo

Prof. Raivo Uibo


Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Cell
Verified
Journal Article
Closed access
Tommi VatanenTommi Vatanen
Tommi Vatanen
AKAleksandar D. Kostic
Aleksandar D. Kostic
EDEva D’hEnnezel
Eva D’hEnnezel
HSHeli Siljander
Heli Siljander
EFEric A. Franzosa
Eric A. Franzosa
RXRamnik J. Xavier
Ramnik J. Xavier

1 July 2016 in Cell
Verified
Journal Article
Open access
SMSteffen Meyer
Steffen Meyer
MWMartin Woodward
Martin Woodward
CHChristina Hertel
Christina Hertel
PVPhilip Vlaicu
Philip Vlaicu
YHYasmin Haque
Yasmin Haque
APAleksandr Peet
Aleksandr Peet
APS1/APECED patients are defined by defects in the autoimmune regulator (AIRE) that mediates central T cell tolerance to many self-antigens. AIRE deficiency also affects B cell tolerance, but this is incompletely understood. Here we show that most APS1/APECED patients displayed B cell autoreactivity toward unique sets of approximately 100 self-proteins. Thereby, autoantibodies from 81 patients collectively detected many thousands of human proteins. The loss of B cell tolerance seemingly occurred during antibody affinity maturation, an obligatorily T cell-dependent step. Consistent with this, many APS1/APECED patients harbored extremely high-affinity, neutralizing autoantibodies, particularly against specific cytokines. Such antibodies were biologically active in vitro and in vivo, and those neutralizing type I interferons (IFNs) showed a striking inverse correlation with type I diabetes, not shown by other anti-cytokine antibodies. Thus, naturally occurring human autoantibodies may actively limit disease and be of therapeutic utility.

17 December 2018 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
Tommi VatanenTommi Vatanen
Tommi Vatanen
DPDamian R. Plichta
Damian R. Plichta
JSJuhi Somani
Juhi Somani
PMPhilipp C. Münch
Philipp C. Münch
TATimothy D. Arthur
Timothy D. Arthur
RXRamnik J. Xavier
Ramnik J. Xavier
The human gut microbiome matures towards the adult composition during the first years of life and is implicated in early immune development. Here, we investigate the effects of microbial genomic diversity on gut microbiome development using integrated early childhood data sets collected in the DIABIMMUNE study in Finland, Estonia and Russian Karelia. We show that gut microbial diversity is associated with household location and linear growth of children. Single nucleotide polymorphism- and metagenomic assembly-based strain tracking revealed large and highly dynamic microbial pangenomes, especially in the genus Bacteroides, in which we identified evidence of variability deriving from Bacteroides-targeting bacteriophages. Our analyses revealed functional consequences of strain diversity; only 10% of Finnish infants harboured Bifidobacterium longum subsp. infantis, a subspecies specialized in human milk metabolism, whereas Russian infants commonly maintained a probiotic Bifidobacterium bifidum strain in infancy. Groups of bacteria contributing to diverse, characterized metabolic pathways converged to highly subject-specific configurations over the first two years of life. This longitudinal study extends the current view of early gut microbial community assembly based on strain-level genomic variation.

1 June 2016 in Cell
Verified
Journal Article
Closed access
Tommi VatanenTommi Vatanen
Tommi Vatanen
AKAleksandar D. Kostic
Aleksandar D. Kostic
EDEva D’hennezel
Eva D’hennezel
HSHeli Siljander
Heli Siljander
EFEric A. Franzosa
Eric A. Franzosa
RXRamnik J. Xavier
Ramnik J. Xavier

1 March 2010 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ABAndrea T. Borchers
Andrea T. Borchers
RURaivo Uibo
Raivo Uibo
MGM.E. Gershwin
M.E. Gershwin

15 March 2009 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FHFrançois-Xavier Hubert
François-Xavier Hubert
SKSarah A Kinkel
Sarah A Kinkel
PCPauline E Crewther
Pauline E Crewther
PCPing Z. F. Cannon
Ping Z. F. Cannon
KWKylie E Webster
Kylie E Webster
HSHamish S Scott
Hamish S Scott
Autoimmune regulator (AIRE) is an important transcription regulator that mediates a role in central tolerance via promoting the “promiscuous” expression of tissue-specific Ags in the thymus. Although several mouse models of Aire deficiency have been described, none has analyzed the phenotype induced by a mutation that emulates the common 13-bp deletion in human APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy) by disrupting the first plant homeodomain in exon 8. Aire-deficient mice with a corresponding mutation showed some disturbance of the medullary epithelial compartment, but at the phenotypic level their T cell compartment appeared relatively normal in the thymus and periphery. An increase in the number of activated T cells was evident, and autoantibodies against several organs were detected. At the histological level, lymphocytic infiltration of several organs indicated the development of autoimmunity, although symptoms were mild and the quality of life for Aire-deficient mice appeared equivalent to wild-type littermates, with the exception of male infertility. Vβ and CDR3 length analysis suggested that each Aire-deficient mouse developed its own polyclonal autoimmune repertoire. Finally, given the prevalence of candidiasis in APECED patients, we examined the control of infection with Candida albicans in Aire-deficient mice. No increase in disease susceptibility was found for either oral or systemic infection. These observations support the view that additional genetic and/or environmental factors contribute substantially to the overt nature of autoimmunity associated with Aire mutations, even for mutations identical to those found in humans with APECED.